Fintel reports that on June 24, 2025, Guggenheim initiated coverage of Amylyx Pharmaceuticals (NasdaqGS:AMLX) with a Buy recommendation. Analyst Price Forecast Suggests 119.44% Upside As of June 20, ...

Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...

Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...

Do you want to learn a new sport or hobby, and you’re looking for lessons within a budget? The online platform Teach Me To is ...

Chemistry falls under the umbrella of natural sciences, alongside other fields like biology, geology and physics. Chemistry ...

The cannabinoid industry is transitioning from early-stage exploration to scientifically validated, regulatory-backed ...

Albert Shirakian, CEO of Retina Vitreous Associates Medical Group, joins the Armenian EyeCare Project's Board of Directors, ...

Fintel reports that on June 26, 2025, UBS upgraded their outlook for Amcor (NYSE:AMCR) from Neutral to Buy. Analyst Price ...

UCSF researchers recently created the world's first shape-shifting synthetic proteins using artificial intelligence (AI). The ...

The preservative thimerosal has been removed from all but a few vaccines, and studies have confirmed no link to ...

If Kennedy had added some of these new people to the advisory committee rather than simply firing the entire committee, he ...